Although we recently showed a comprehensive profile of the growth factors and their binding proteins based on the Olink plasma proteomics (5, 6), the changes in the IGFs system, the magnitude, and the significance of these alterations in COVID-19 patients require further investigation, especially with regards to the possible competition between IGF and insulin signaling mentioned above (20–22). The gene discussed is IGF1; the disease is COVID-19.